Arrowstreet Capital
KURA icon

Arrowstreet Capital’s Kura Oncology KURA Stock Holding History

Arrowstreet Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5M Buy
+1,410,275
New +$13.3M 0.01% 944
2021
Q1 		– Sell
-49,913
Closed -$1.63M – 2385
2020
Q4 		$1.63M Buy
+49,913
New +$1.75M ﹤0.01% 1673
2020
Q3 		– Sell
-55,186
Closed -$900K – 2423
2020
Q2 		$900K Buy
+55,186
New +$796K ﹤0.01% 1809

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Arrowstreet Capital's KURA Position: Q2 2026 in Review

Arrowstreet Capital opened a new position in Kura Oncology (KURA) in Q2 2026: 1,410,275 shares worth $15.5M. The stake represents 0.01% of the portfolio and ranks #944 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in KURA as recently as Q4 2020.

Arrowstreet Capital first reported a position in KURA in Q2 2020 and has held it in 3 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Arrowstreet Capital held 1,410,275 shares of Kura Oncology worth $15.5M as of Q2 2026.
  • Kura Oncology was a new Arrowstreet Capital position in Q2 2026.
  • Kura Oncology made up 0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #944 holding.
  • Arrowstreet Capital first reported a position in Kura Oncology in Q2 2020 and has held it in 3 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.